<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug</title>
	<atom:link href="http://www.xconomy.com/boston/2009/09/02/gloucester-gears-up-for-fda-panel-vote-on-lymphoma-drug/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/09/02/gloucester-gears-up-for-fda-panel-vote-on-lymphoma-drug/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: FDA Advisory Committee Recommends Approval Of Allos Therapeutics - RTT News &#124; The Leukemia Lymphoma Cancer Blog</title>
		<link>http://www.xconomy.com/boston/2009/09/02/gloucester-gears-up-for-fda-panel-vote-on-lymphoma-drug/comment-page-1/#comment-80222</link>
		<dc:creator>FDA Advisory Committee Recommends Approval Of Allos Therapeutics - RTT News &#124; The Leukemia Lymphoma Cancer Blog</dc:creator>
		<pubDate>Mon, 07 Sep 2009 11:40:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=39890#comment-80222</guid>
		<description>[...] Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug - XconomyYou can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth. The Cambridge, MA-based biotech company will try to make its case today [...]</description>
		<content:encoded><![CDATA[<p>[...] Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug – XconomyYou can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth. The Cambridge, MA-based biotech company will try to make its case today [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug - Xconomy &#124; The Leukemia Lymphoma Cancer Blog</title>
		<link>http://www.xconomy.com/boston/2009/09/02/gloucester-gears-up-for-fda-panel-vote-on-lymphoma-drug/comment-page-1/#comment-79171</link>
		<dc:creator>Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug - Xconomy &#124; The Leukemia Lymphoma Cancer Blog</dc:creator>
		<pubDate>Wed, 02 Sep 2009 22:49:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=39890#comment-79171</guid>
		<description>[...] You can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth. The Cambridge, MA-based biotech company will try to make its case today Read More  [...]</description>
		<content:encoded><![CDATA[<p>[...] You can bet that the people who just put $29 million into Gloucester Pharmaceuticals a few days ago will be watching very closely today for signs they got their money’s worth. The Cambridge, MA-based biotech company will try to make its case today Read More  [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

